An air-compressing intermittent-pressure method enables the fabrication of transplantable thick tissues displaying vascularization and a high protein secretion capacity, with potential ...
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.